Outcomes in Patients With Mitral Annular Disjunction and an Implantable‐Cardioverter Defibrillator
In our cohort of patients with MAD and ICD, appropriate ICD therapies were common. Most appropriate ICD therapies were delivered for polymorphic VT or VF. Larger studies are needed to elucidate the mechanisms of VAs and refine risk stratification in MAD.
Authors
- John R. Giudicessi (ORCID: https://orcid.org/0000-0001-5871-0265)
- Konstantinos C. Siontis (ORCID: https://orcid.org/0000-0002-6658-0971)
- Abhishek Deshmukh (ORCID: https://orcid.org/0000-0002-9560-1102)
- Fatima M. Ezzeddine (ORCID: https://orcid.org/0000-0002-6204-4557)
- Gurukripa N. Kowlgi (ORCID: https://orcid.org/0000-0002-0913-3497)
- Malini Madhavan (ORCID: https://orcid.org/0000-0002-2831-4568)
- Jinho Shin (ORCID: https://orcid.org/0000-0001-6706-6504)
- Michael John Ackerman (ORCID: https://orcid.org/0000-0002-8011-3333)
- Freddy Del‐Carpio Munoz (ORCID: https://orcid.org/0000-0001-9511-1245)
- Samuel J. Asirvatham (ORCID: https://orcid.org/0000-0001-9835-5536)
- Ammar M. Killu (ORCID: https://orcid.org/0000-0002-5525-1806)
- Christopher J. McLeod
Institutions
- Mayo Clinic (US)
- Jacksonville College (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1111/jce.16612
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00